Clinical Trial Update: Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 exploratory trial assessing TCR-T cells targeting MAGE-A4 in advanced mesenchymal malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• MAGE-A4-targeted TCR-T cell therapy

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Advanced Mesenchymal Malignancies | Phase 1 | Status: RECRUITING